STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Penumbra, Inc. to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Penumbra (NYSE: PEN) has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. The company's management team will deliver a presentation on Monday, January 13, 2025, at 6:00pm ET/3:00pm PT.

Investors and interested parties can access a webcast of the presentation through the 'Events and Presentations' section under the 'Investors' tab on Penumbra's website. The presentation recording will remain available for a minimum of two weeks following the event.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

-0.29% News Effect

On the day this news was published, PEN declined 0.29%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

ALAMEDA, Calif., Dec. 30, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025.

Event:     43rd Annual J.P. Morgan Healthcare Conference
Date:       Monday, January 13, 2025
Time:      6:00pm ET/3:00pm PT

A webcast of the presentation can be accessed on the "Events and Presentations" section under the "Investors" tab of the company's website at www.penumbrainc.com.  The webcast will be available on the company's website for at least two weeks following the event.

About Penumbra 
Penumbra, Inc., the world's leading thrombectomy company, is focused on developing the most innovative technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism such as pulmonary embolism, and acute limb ischemia. Our broad portfolio, which includes computer assisted vacuum thrombectomy (CAVT), centers on removing blood clots from head-to-toe with speed, safety and simplicity. By pioneering these innovations, we support healthcare providers, hospitals and clinics in more than 100 countries, working to improve patient outcomes and quality of life. For more information, visit www.penumbrainc.com and connect on Instagram, LinkedIn and X.

Investor Relations
Penumbra, Inc.
investors@penumbrainc.com 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/penumbra-inc-to-present-at-the-43rd-annual-jp-morgan-healthcare-conference-302337761.html

SOURCE Penumbra, Inc.

FAQ

When is Penumbra (PEN) presenting at the 2025 J.P. Morgan Healthcare Conference?

Penumbra is scheduled to present at the conference on Monday, January 13, 2025, at 6:00pm ET/3:00pm PT.

How can investors watch Penumbra's (PEN) J.P. Morgan Healthcare Conference presentation?

Investors can watch the presentation via webcast on Penumbra's website under the 'Events and Presentations' section of the 'Investors' tab at www.penumbrainc.com.

How long will Penumbra's (PEN) 2025 J.P. Morgan Conference presentation be available online?

The webcast will be available on Penumbra's website for at least two weeks following the event.

Which Penumbra (PEN) executives will be presenting at the 2025 J.P. Morgan Healthcare Conference?

The press release indicates that the management team will be presenting, but does not specify which executives will participate.
Penumbra Inc

NYSE:PEN

PEN Rankings

PEN Latest News

PEN Latest SEC Filings

PEN Stock Data

11.55B
37.48M
3.66%
93.38%
4.59%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
ALAMEDA